Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

William R Hiatt

TitleProfessor
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM-MED
Phone303/860-9900

    Collapse Research 
    Collapse research activities and funding
    K07HL002825     (HIATT, WILLIAM READ)Jul 23, 1993 - Jun 30, 1999
    NIH/NHLBI
    ACADEMIC AWARD IN VASCULAR DISEASE
    Role: Principal Investigator

    U01HL130219     (HIATT, WILLIAM READ)Sep 15, 2016 - Jun 30, 2021
    NIH/NHLBI
    KidsDOTT-DCC
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Christiansen CL, Miller MJ, Murray AM, Stephenson RO, Stevens-Lapsley JE, Hiatt WR, Schenkman ML. Behavior-change intervention targeting physical function, walking, and disability after dysvascular amputation: A randomized controlled pilot trial. Arch Phys Med Rehabil. 2018 May 07. PMID: 29746823.
      View in: PubMed
    2. Rogers RK, Hiatt WR, Patel MR, Shishehbor MH, White R, Khan ND, Bhalla NP, Jones WS, Low Wang CC. Ticagrelor in Peripheral Artery Disease Endovascular Revascularization (TI-PAD): Challenges in clinical trial execution. Vasc Med. 2018 Apr 01; 1358863X18760996. PMID: 29629845.
      View in: PubMed
    3. Raparelli V, Pastori D, Pignataro SF, Vestri AR, Pignatelli P, Cangemi R, Proietti M, Davì G, Hiatt WR, Lip GYH, Corazza GR, Perticone F, Violi F, Basili S. Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study. Intern Emerg Med. 2018 Mar 26. PMID: 29582316.
      View in: PubMed
    4. Brass EP, Hiatt WR. Response by Brass and Hiatt to Letter Regarding Article, "Aspirin Monotherapy Should Not Be Recommended for Cardioprotection in Patients With Symptomatic Peripheral Artery Disease". Circulation. 2018 Mar 20; 137(12):1304. PMID: 29555719.
      View in: PubMed
    5. Norgren L, Patel MR, Hiatt WR, Wojdyla DM, Fowkes FGR, Baumgartner I, Mahaffey KW, Berger JS, Jones WS, Katona BG, Held P, Blomster JI, Rockhold FW, Björck M. Outcomes of Patients with Critical Limb Ischaemia in the EUCLID Trial. Eur J Vasc Endovasc Surg. 2018 Jan; 55(1):109-117. PMID: 29273390.
      View in: PubMed
    6. Hess CN, Hiatt WR. Response by Hess and Hiatt to Letter Regarding Article, "A Structured Review of Antithrombotic Therapy in Peripheral Artery Disease With a Focus on Revascularization: A TASC (InterSociety Consensus for the Management of Peripheral Artery Disease) Initiative". Circulation. 2017 Dec 19; 136(25):2524-2525. PMID: 29255130.
      View in: PubMed
    7. Hess CN, Low Wang CC, Hiatt WR. PCSK9 Inhibitors: Mechanisms of Action, Metabolic Effects, and Clinical Outcomes. Annu Rev Med. 2018 Jan 29; 69:133-145. PMID: 29095667.
      View in: PubMed
    8. Collins SP, Thorn M, Nowak RM, Levy PD, Fermann GJ, Hiestand BC, Cowart TD, Venuti RP, Hiatt WR, Foo S, Pang PS. Feasibility of Serial 6-min Walk Tests in Patients with Acute Heart Failure. J Clin Med. 2017 Sep 11; 6(9). PMID: 28891981.
      View in: PubMed
    9. Brass EP, Hiatt WR. Aspirin Monotherapy Should Not Be Recommended for Cardioprotection in Patients With Symptomatic Peripheral Artery Disease. Circulation. 2017 Aug 29; 136(9):785-786. PMID: 28847795.
      View in: PubMed
    10. Hess CN, Norgren L, Ansel GM, Capell WH, Fletcher JP, Fowkes FGR, Gottsäter A, Hitos K, Jaff MR, Nordanstig J, Hiatt WR. A Structured Review of Antithrombotic Therapy in Peripheral Artery Disease With a Focus on Revascularization: A TASC (InterSociety Consensus for the Management of Peripheral Artery Disease) Initiative. Circulation. 2017 Jun 20; 135(25):2534-2555. PMID: 28630267.
      View in: PubMed
    11. Jones WS, Hiatt WR, Patel MR. Response by Jones et al to Letter Regarding Article, "Ticagrelor Compared With Clopidogrel in Patients With Prior Lower Extremity Revascularization for Peripheral Artery Disease". Circulation. 2017 Jun 06; 135(23):e1109-e1110. PMID: 28584036.
      View in: PubMed
    12. Hiatt WR. Alan Hirsch, MD: 1954-2017. Circ Res. 2017 May 26; 120(11):1702-1703. PMID: 28546350.
      View in: PubMed
    13. Hiatt WR, Rogers RK. The Treatment Gap in Peripheral Artery Disease. J Am Coll Cardiol. 2017 May 09; 69(18):2301-2303. PMID: 28473135.
      View in: PubMed
    14. Patel MR, Fowkes FG, Hiatt WR. Ticagrelor versus Clopidogrel in Peripheral Artery Disease. N Engl J Med. 2017 04 13; 376(15):1488-9. PMID: 28402763.
      View in: PubMed
    15. Perin EC, Murphy MP, March KL, Bolli R, Loughran J, Yang PC, Leeper NJ, Dalman RL, Alexander J, Henry TD, Traverse JH, Pepine CJ, Anderson RD, Berceli S, Willerson JT, Muthupillai R, Gahremanpour A, Raveendran G, Velasquez O, Hare JM, Hernandez Schulman I, Kasi VS, Hiatt WR, Ambale-Venkatesh B, Lima JA, Taylor DA, Resende M, Gee AP, Durett AG, Bloom J, Richman S, G'Sell P, Williams S, Khan F, Gyang Ross E, Santoso MR, Goldman J, Leach D, Handberg E, Cheong B, Piece N, DiFede D, Bruhn-Ding B, Caldwell E, Bettencourt J, Lai D, Piller L, Simpson L, Cohen M, Sayre SL, Vojvodic RW, Moyé L, Ebert RF, Simari RD, Hirsch AT. Evaluation of Cell Therapy on Exercise Performance and Limb Perfusion in Peripheral Artery Disease: The CCTRN PACE Trial (Patients With Intermittent Claudication Injected With ALDH Bright Cells). Circulation. 2017 Apr 11; 135(15):1417-1428. PMID: 28209728.
      View in: PubMed
    16. Basili S, Loffredo L, Pastori D, Proietti M, Farcomeni A, Vestri AR, Pignatelli P, Davì G, Hiatt WR, Lip GY, Corazza GR, Perticone F, Violi F. Carotid plaque detection improves the predictive value of CHA2DS2-VASc score in patients with non-valvular atrial fibrillation: The ARAPACIS Study. Int J Cardiol. 2017 Mar 15; 231:143-149. PMID: 28087176.
      View in: PubMed
    17. Hammad TA, Hiatt WR, Gornik HL, Shishehbor MH. Prognostic value of an increase in post-exercise ankle-brachial index. Vasc Med. 2017 06; 22(3):204-209. PMID: 27940923.
      View in: PubMed
    18. Jones WS, Baumgartner I, Hiatt WR, Heizer G, Conte MS, White CJ, Berger JS, Held P, Katona BG, Mahaffey KW, Norgren L, Blomster J, Millegård M, Reist C, Patel MR, Fowkes FG. Ticagrelor Compared With Clopidogrel in Patients With Prior Lower Extremity Revascularization for Peripheral Artery Disease. Circulation. 2017 Jan 17; 135(3):241-250. PMID: 27840336.
      View in: PubMed
    19. Hiatt WR, Fowkes FG, Heizer G, Berger JS, Baumgartner I, Held P, Katona BG, Mahaffey KW, Norgren L, Jones WS, Blomster J, Millegård M, Reist C, Patel MR. Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease. N Engl J Med. 2017 01 05; 376(1):32-40. PMID: 27959717.
      View in: PubMed
    20. Eun JC, Hiatt WR, Glebova NO. Nonatherosclerotic limb ischemia: Prompt evaluation and diagnosis. Cleve Clin J Med. 2016 Oct; 83(10):741-751. PMID: 27726826.
      View in: PubMed
    21. Olin JW, White CJ, Armstrong EJ, Kadian-Dodov D, Hiatt WR. Reply: Endovascular-First Treatment of Peripheral Arterial Disease Remains Controversial. J Am Coll Cardiol. 2016 Sep 27; 68(13):1493. PMID: 27659473.
      View in: PubMed
    22. Everett BM, Hiatt WR. Finding Efficacy in a Safety Trial: Empagliflozin and Cardiovascular Death. Circulation. 2016 Sep 06; 134(10):773-5. PMID: 27601559.
      View in: PubMed
    23. Patel MR, Armstrong PW, Bhatt DL, Braunwald E, Camm AJ, Fox KA, Harrington RA, Hiatt WR, James SK, Kirtane AJ, Leon MB, Lincoff AM, Mahaffey KW, Mauri L, Mehran R, Mehta SR, Montalescot G, Nicholls SJ, Perkovic V, Peterson ED, Pocock SJ, Roe MT, Sabatine MS, Sekeres M, Solomon SD, Steg G, Stone GW, Van de Werf F, Wallentin L, White HD, Gibson M. Sharing Data from Cardiovascular Clinical Trials--A Proposal. N Engl J Med. 2016 Aug 04; 375(5):407-9. PMID: 27518659.
      View in: PubMed
    24. Fowkes FG, Forster RB, Levin CE, Naidoo NG, Roy A, Shu C, Spertus J, Fang K, Bechara-Zamudio L, Catalano M, Visonà A, Nikol S, Fletcher JP, Jaff MR, Hiatt WR, Norgren L. Prioritization of treatments for lower extremity peripheral artery disease in low- and middle-income countries. Int Angiol. 2017 Jun; 36(3):203-215. PMID: 27386953.
      View in: PubMed
    25. Kittelson JM, Steg PG, Halperin JL, Goldenberg NA, Schulman S, Spyropoulos AC, Kessler CM, Turpie AG, Cutler NR, Hiatt WR. Bivariate evaluation of thromboembolism and bleeding in clinical trials of anticoagulants in patients with atrial fibrillation. Thromb Haemost. 2016 08 30; 116(3):544-53. PMID: 27346176.
      View in: PubMed
    26. Hiatt WR, Rogers RK. The Development of Therapeutics for Peripheral Artery Disease: A Unique Cardiovascular Risk Population. J Am Coll Cardiol. 2016 Jun 14; 67(23):2729-2731. PMID: 27282893.
      View in: PubMed
    27. Low Wang CC, Hess CN, Hiatt WR, Goldfine AB. Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus - Mechanisms, Management, and Clinical Considerations. Circulation. 2016 Jun 14; 133(24):2459-502. PMID: 27297342; PMCID: PMC4910510 [Available on 06/14/17].
    28. Smith RJ, Goldfine AB, Hiatt WR. Evaluating the Cardiovascular Safety of New Medications for Type 2 Diabetes: Time to Reassess? Diabetes Care. 2016 05; 39(5):738-42. PMID: 27208377.
      View in: PubMed
    29. Olin JW, White CJ, Armstrong EJ, Kadian-Dodov D, Hiatt WR. Peripheral Artery Disease: Evolving Role of Exercise, Medical Therapy, and Endovascular Options. J Am Coll Cardiol. 2016 Mar 22; 67(11):1338-57. PMID: 26988957.
      View in: PubMed
    30. Raskob GE, Spyropoulos AC, Zrubek J, Ageno W, Albers G, Elliott CG, Halperin J, Haskell L, Hiatt WR, Maynard GA, Peters G, Spiro T, Steg PG, Suh EY, Weitz JI. The MARINER trial of rivaroxaban after hospital discharge for medical patients at high risk of VTE. Design, rationale, and clinical implications. Thromb Haemost. 2016 06 02; 115(6):1240-8. PMID: 26842902.
      View in: PubMed
    31. Berger JS, Katona BG, Jones WS, Patel MR, Norgren L, Baumgartner I, Blomster J, Mahaffey KW, Held P, Millegård M, Heizer G, Reist C, Fowkes FG, Hiatt WR. Design and rationale for the Effects of Ticagrelor and Clopidogrel in Patients with Peripheral Artery Disease (EUCLID) trial. Am Heart J. 2016 May; 175:86-93. PMID: 27179727.
      View in: PubMed
    32. Violi F, Davì G, Proietti M, Pastori D, Hiatt WR, Corazza GR, Perticone F, Pignatelli P, Farcomeni A, Vestri AR, Lip GY, Basili S. Ankle-Brachial Index and cardiovascular events in atrial fibrillation. The ARAPACIS Study. Thromb Haemost. 2016 Apr; 115(4):856-63. PMID: 26740316.
      View in: PubMed
    33. Jaff MR, White CJ, Hiatt WR, Fowkes GR, Dormandy J, Razavi M, Reekers J, Norgren L. An Update on Methods for Revascularization and Expansion of the TASC Lesion Classification to Include Below-the-Knee Arteries: A Supplement to the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II): The TASC Steering Comittee(.). Ann Vasc Dis. 2015; 8(4):343-57. PMID: 26730266; PMCID: PMC4691515.
    34. Everett BM, Smith RJ, Hiatt WR. Reducing LDL with PCSK9 Inhibitors--The Clinical Benefit of Lipid Drugs. N Engl J Med. 2015 Oct 22; 373(17):1588-91. PMID: 26444323.
      View in: PubMed
    35. Jaff MR, White CJ, Hiatt WR, Fowkes GR, Dormandy J, Razavi M, Reekers J, Norgren L. An Update on Methods for Revascularization and Expansion of the TASC Lesion Classification to Include Below-the-Knee Arteries: A Supplement to the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Vasc Med. 2015 Oct; 20(5):465-78. PMID: 26268268.
      View in: PubMed
    36. Goldenberg NA, Abshire T, Blatchford PJ, Fenton LZ, Halperin JL, Hiatt WR, Kessler CM, Kittelson JM, Manco-Johnson MJ, Spyropoulos AC, Steg PG, Stence NV, Turpie AG, Schulman S. Multicenter randomized controlled trial on Duration of Therapy for Thrombosis in Children and Young Adults (the Kids-DOTT trial): pilot/feasibility phase findings. J Thromb Haemost. 2015 Sep; 13(9):1597-605. PMID: 26118944; PMCID: PMC4561031.
    37. Jaff MR, White CJ, Hiatt WR, Fowkes GR, Dormandy J, Razavi M, Reekers J, Norgren L. An update on methods for revascularization and expansion of the TASC lesion classification to include below-the-knee arteries: A supplement to the inter-society consensus for the management of peripheral arterial disease (TASC II): The TASC steering committee. Catheter Cardiovasc Interv. 2015 Oct; 86(4):611-25. PMID: 26256456.
      View in: PubMed
    38. Low Wang CC, Galinkin JL, Hiatt WR. Toxicity of a novel therapeutic agent targeting mitochondrial complex I. Clin Pharmacol Ther. 2015 Nov; 98(5):551-9. PMID: 26108785.
      View in: PubMed
    39. Jaff MR, White CJ, Hiatt WR, Fowkes GR, Dormandy J, Razavi M, Reekers J, Norgren L. An Update on Methods for Revascularization and Expansion of the TASC Lesion Classification to Include Below-the-Knee Arteries: A Supplement to the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Endovasc Ther. 2015 Oct; 22(5):663-77. PMID: 26239796.
      View in: PubMed
    40. Pastori D, Pignatelli P, Farcomeni A, Cangemi R, Hiatt WR, Bartimoccia S, Nocella C, Vicario T, Bucci T, Carnevale R, Lip GY, Violi F. Urinary 11-dehydro-thromboxane B2 is associated with cardiovascular events and mortality in patients with atrial fibrillation. Am Heart J. 2015 Sep; 170(3):490-7.e1. PMID: 26385032.
      View in: PubMed
    41. Violi F, Pastori D, Perticone F, Hiatt WR, Sciacqua A, Basili S, Proietti M, Corazza GR, Lip GY, Pignatelli P. Relationship between low Ankle-Brachial Index and rapid renal function decline in patients with atrial fibrillation: a prospective multicentre cohort study. BMJ Open. 2015 May 21; 5(5):e008026. PMID: 25998039; PMCID: PMC4442172.
    42. Hiatt WR, Armstrong EJ, Larson CJ, Brass EP. Pathogenesis of the limb manifestations and exercise limitations in peripheral artery disease. Circ Res. 2015 Apr 24; 116(9):1527-39. PMID: 25908726.
      View in: PubMed
    43. Fordyce CB, Roe MT, Ahmad T, Libby P, Borer JS, Hiatt WR, Bristow MR, Packer M, Wasserman SM, Braunstein N, Pitt B, DeMets DL, Cooper-Arnold K, Armstrong PW, Berkowitz SD, Scott R, Prats J, Galis ZS, Stockbridge N, Peterson ED, Califf RM. Cardiovascular drug development: is it dead or just hibernating? J Am Coll Cardiol. 2015 Apr 21; 65(15):1567-82. PMID: 25881939.
      View in: PubMed
    44. Patel MR, Conte MS, Cutlip DE, Dib N, Geraghty P, Gray W, Hiatt WR, Ho M, Ikeda K, Ikeno F, Jaff MR, Jones WS, Kawahara M, Lookstein RA, Mehran R, Misra S, Norgren L, Olin JW, Povsic TJ, Rosenfield K, Rundback J, Shamoun F, Tcheng J, Tsai TT, Suzuki Y, Vranckx P, Wiechmann BN, White CJ, Yokoi H, Krucoff MW. Evaluation and treatment of patients with lower extremity peripheral artery disease: consensus definitions from Peripheral Academic Research Consortium (PARC). J Am Coll Cardiol. 2015 Mar 10; 65(9):931-41. PMID: 25744011; PMCID: PMC4874808.
    45. Mays RJ, Hiatt WR, Casserly IP, Rogers RK, Main DS, Kohrt WM, Ho PM, Regensteiner JG. Community-based walking exercise for peripheral artery disease: An exploratory pilot study. Vasc Med. 2015 Aug; 20(4):339-47. PMID: 25755148; PMCID: PMC4749131.
    46. Creager MA, Hiatt WR, Hirsch AT, Olin JW, Jaff MR, Cooke JP, Rooke T, Beckman JA, Froehlich JB. The Society for Vascular Medicine: the first quarter century. Vasc Med. 2015 Feb; 20(1):60-8. PMID: 25722420.
      View in: PubMed
    47. Sager PT, Seltzer J, Turner JR, Anderson JL, Hiatt WR, Kowey P, Prochaska JJ, Stockbridge N, White WB. Cardiovascular Safety Outcome Trials: A meeting report from the Cardiac Safety Research Consortium. Am Heart J. 2015 Apr; 169(4):486-95. PMID: 25819855.
      View in: PubMed
    48. Olson E, Demopoulos L, Haws TF, Hu E, Fang Z, Mahar KM, Qin P, Lepore J, Bauer TA, Hiatt WR. Short-term treatment with a novel HIF-prolyl hydroxylase inhibitor (GSK1278863) failed to improve measures of performance in subjects with claudication-limited peripheral artery disease. Vasc Med. 2014 Dec; 19(6):473-82. PMID: 25377872.
      View in: PubMed
    49. Stein RA, Rockman CB, Guo Y, Adelman MA, Riles T, Hiatt WR, Berger JS. Association between physical activity and peripheral artery disease and carotid artery stenosis in a self-referred population of 3 million adults. Arterioscler Thromb Vasc Biol. 2015 Jan; 35(1):206-12. PMID: 25359858; PMCID: PMC4518860.
    50. Subherwal S, Patel MR, Chiswell K, Tidemann-Miller BA, Jones WS, Conte MS, White CJ, Bhatt DL, Laird JR, Hiatt WR, Tasneem A, Califf RM. Clinical trials in peripheral vascular disease: pipeline and trial designs: an evaluation of the ClinicalTrials.gov database. Circulation. 2014 Nov 11; 130(20):1812-9. PMID: 25239436; PMCID: PMC4362518.
    51. Hiatt WR. Heart failure and peripheral artery disease: an unappreciated association. JACC Heart Fail. 2014 Oct; 2(5):455-6. PMID: 25194283.
      View in: PubMed
    52. Perin EC, Murphy M, Cooke JP, Moyé L, Henry TD, Bettencourt J, Gahremanpour A, Leeper N, Anderson RD, Hiatt WR, Lima JA, Venkatesh B, Sayre SL, Vojvodic RW, Taylor DA, Ebert RF, Hirsch AT. Rationale and design for PACE: patients with intermittent claudication injected with ALDH bright cells. Am Heart J. 2014 Nov; 168(5):667-73. PMID: 25440794; PMCID: PMC4254580.
    53. Hiatt WR, Rogers RK, Brass EP. The treadmill is a better functional test than the 6-minute walk test in therapeutic trials of patients with peripheral artery disease. Circulation. 2014 Jul 01; 130(1):69-78. PMID: 24982118.
      View in: PubMed
    54. Hiatt WR, Rogers K, Brass EP. Response to McDermott. Circulation. 2014 Jul 01; 130(1):68. PMID: 25110791.
      View in: PubMed
    55. Bauer TA, Wolff AA, Hirsch AT, Meng LL, Rogers K, Malik FI, Hiatt WR. Effect of tirasemtiv, a selective activator of the fast skeletal muscle troponin complex, in patients with peripheral artery disease. Vasc Med. 2014 Aug; 19(4):297-306. PMID: 24872402.
      View in: PubMed
    56. Patel MR, Becker RC, Wojdyla DM, Emanuelsson H, Hiatt WR, Horrow J, Husted S, Mahaffey KW, Steg PG, Storey RF, Wallentin L, James SK. Cardiovascular events in acute coronary syndrome patients with peripheral arterial disease treated with ticagrelor compared with clopidogrel: Data from the PLATO Trial. Eur J Prev Cardiol. 2015 Jun; 22(6):734-42. PMID: 24830710.
      View in: PubMed
    57. Nehler MR, Duval S, Diao L, Annex BH, Hiatt WR, Rogers K, Zakharyan A, Hirsch AT. Epidemiology of peripheral arterial disease and critical limb ischemia in an insured national population. J Vasc Surg. 2014 Sep; 60(3):686-95.e2. PMID: 24820900.
      View in: PubMed
    58. Norgren L, Hiatt WR, Jaff MR. Response to ‘Statement from the European Society of Vascular Surgery and the World Federation of Vascular Surgery Societies’ Inter-Society Consensus Document (TASC) III and International Standards for Vascular Care (ISVaC). Eur J Vasc Endovasc Surg. 2014 May; 47(5):461. PMID: 24851281.
      View in: PubMed
    59. Hiatt WR, Smith RJ. Assessing the clinical benefits of lipid-disorder drugs. N Engl J Med. 2014 Jan 30; 370(5):396-9. PMID: 24476429.
      View in: PubMed
    60. Fowkes FG, Murray GD, Butcher I, Folsom AR, Hirsch AT, Couper DJ, Debacker G, Kornitzer M, Newman AB, Sutton-Tyrrell KC, Cushman M, Lee AJ, Price JF, D'Agostino RB, Murabito JM, Norman P, Masaki KH, Bouter LM, Heine RJ, Stehouwer CD, McDermott MM, Stoffers HE, Knottnerus JA, Ogren M, Hedblad B, Koenig W, Meisinger C, Cauley JA, Franco O, Hunink MG, Hofman A, Witteman JC, Criqui MH, Langer RD, Hiatt WR, Hamman RF. Development and validation of an ankle brachial index risk model for the prediction of cardiovascular events. Eur J Prev Cardiol. 2014 Mar; 21(3):310-20. PMID: 24367001.
      View in: PubMed
    61. Mohler ER, Hiatt WR, Gornik HL, Kevil CG, Quyyumi A, Haynes WG, Annex BH. Sodium nitrite in patients with peripheral artery disease and diabetes mellitus: safety, walking distance and endothelial function. Vasc Med. 2014 Feb; 19(1):9-17. PMID: 24363302.
      View in: PubMed
    62. Violi F, Davì G, Hiatt W, Lip GY, Corazza GR, Perticone F, Proietti M, Pignatelli P, Vestri AR, Basili S. Reply: ankle-brachial index in patients with nonvalvular atrial fibrillation. J Am Coll Cardiol. 2014 Apr 15; 63(14):1457-8. PMID: 24315905.
      View in: PubMed
    63. Mays RJ, Rogers RK, Hiatt WR, Regensteiner JG. Community walking programs for treatment of peripheral artery disease. J Vasc Surg. 2013 Dec; 58(6):1678-87. PMID: 24103409; PMCID: PMC3904661.
    64. Smith RJ, Hiatt WR. Two new drugs for homozygous familial hypercholesterolemia: managing benefits and risks in a rare disorder. JAMA Intern Med. 2013 Sep 09; 173(16):1491-2. PMID: 23649296.
      View in: PubMed
    65. Hiatt WR, Kaul S, Smith RJ. The cardiovascular safety of diabetes drugs--insights from the rosiglitazone experience. N Engl J Med. 2013 Oct 03; 369(14):1285-7. PMID: 23992603.
      View in: PubMed
    66. Violi F, Daví G, Hiatt W, Lip GY, Corazza GR, Perticone F, Proietti M, Pignatelli P, Vestri AR, Basili S. Prevalence of peripheral artery disease by abnormal ankle-brachial index in atrial fibrillation: implications for risk and therapy. J Am Coll Cardiol. 2013 Dec 10; 62(23):2255-6. PMID: 23954332.
      View in: PubMed
    67. Kittelson JM, Spyropoulos AC, Halperin JL, Kessler CM, Schulman S, Steg G, Turpie AG, Cutler NR, Hiatt WR, Goldenberg NA. Balancing risk and benefit in venous thromboembolism trials: concept for a bivariate endpoint trial design and analytic approach. J Thromb Haemost. 2013 Aug; 11(8):1443-8. PMID: 23773172; PMCID: PMC4528967.
    68. Campbell A, Price J, Hiatt WR. Omega-3 fatty acids for intermittent claudication. Cochrane Database Syst Rev. 2013 Jul 04; (7):CD003833. PMID: 23824785.
      View in: PubMed
    69. Hiatt WR. Should an alternate ABI definition be adopted to evaluate risk? J Am Coll Cardiol. 2013 Aug 06; 62(6):560-1. PMID: 23707314.
      View in: PubMed
    70. Brass EP, Cooper LT, Hanson P, Hiatt WR. Association of clinical attributes and treadmill walking performance in patients with claudication due to peripheral artery disease. J Vasc Surg. 2013 Aug; 58(2):396-403. PMID: 23684414.
      View in: PubMed
    71. Cangemi R, Pignatelli P, Carnevale R, Corazza GR, Pastori D, Farcomeni A, Basili S, Davì G, Ferro D, Hiatt WR, Licata G, Lip GY, Loffredo L, Mannucci PM, Vestri A, Violi F. Cholesterol-adjusted vitamin E serum levels are associated with cardiovascular events in patients with non-valvular atrial fibrillation. Int J Cardiol. 2013 Oct 09; 168(4):3241-7. PMID: 23651827.
      View in: PubMed
    72. Hiatt WR. Vascular disease: vorapaxar prevents progression of peripheral artery disease. Nat Rev Cardiol. 2013 Jul; 10(7):367-8. PMID: 23629438.
      View in: PubMed
    73. Misra S, Lookstein R, Rundback J, Hirsch AT, Hiatt WR, Jaff MR, White CR, Conte M, Geraghty P, Patel M, Rosenfield K. Proceedings from the Society of Interventional Radiology research consensus panel on critical limb ischemia. J Vasc Interv Radiol. 2013 Apr; 24(4):451-8. PMID: 23522155; PMCID: PMC3940238.
    74. Brass EP, Koster D, Hiatt WR, Amato A. A systematic review and meta-analysis of propionyl-L-carnitine effects on exercise performance in patients with claudication. Vasc Med. 2013 Feb; 18(1):3-12. PMID: 23321261.
      View in: PubMed
    75. Garg SK, Moser EG, Bode BW, Klaff LJ, Hiatt WR, Beatson C, Snell-Bergeon JK. Effect of sitagliptin on post-prandial glucagon and GLP-1 levels in patients with type 1 diabetes: investigator-initiated, double-blind, randomized, placebo-controlled trial. Endocr Pract. 2013 Jan-Feb; 19(1):19-28. PMID: 23186950.
      View in: PubMed
    76. Spyropoulos AC, Goldenberg NA, Kessler CM, Kittelson J, Schulman S, Turpie AG, Cutler NR, Hiatt WR, Halperin JL. Comparative effectiveness and safety of the novel oral anticoagulants: do the pivotal clinical trials point to a new paradigm? J Thromb Haemost. 2012 Dec; 10(12):2621-4. PMID: 23006126.
      View in: PubMed
    77. Aboyans V, Criqui MH, Abraham P, Allison MA, Creager MA, Diehm C, Fowkes FG, Hiatt WR, Jönsson B, Lacroix P, Marin B, McDermott MM, Norgren L, Pande RL, Preux PM, Stoffers HE, Treat-Jacobson D. Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association. Circulation. 2012 Dec 11; 126(24):2890-909. PMID: 23159553.
      View in: PubMed
    78. Hiatt WR, Zakharyan A, Fung ET, Crutcher G, Smith A, Stanford C, Cooke J. A validated biomarker panel to identify peripheral artery disease. Vasc Med. 2012 Dec; 17(6):386-93. PMID: 23086582.
      View in: PubMed
    79. Hiatt WR, Goldfine AB, Kaul S. Cardiovascular risk assessment in the development of new drugs for obesity. JAMA. 2012 Sep 19; 308(11):1099-100. PMID: 22990267.
      View in: PubMed
    80. Subherwal S, Anstrom KJ, Jones WS, Felker MG, Misra S, Conte MS, Hiatt WR, Patel MR. Use of alternative methodologies for evaluation of composite end points in trials of therapies for critical limb ischemia. Am Heart J. 2012 Sep; 164(3):277-84. PMID: 22980292; PMCID: PMC3950277.
    81. Berger JS, Hiatt WR. Medical therapy in peripheral artery disease. Circulation. 2012 Jul 24; 126(4):491-500. PMID: 22825411.
      View in: PubMed
    82. Kao DP, Hiatt WR, Krantz MJ. Proarrhythmic potential of dronedarone: emerging evidence from spontaneous adverse event reporting. Pharmacotherapy. 2012 Aug; 32(8):767-71. PMID: 22744806; PMCID: PMC3463717.
    83. Goldenberg NA, Krantz MJ, Hiatt WR. L-Carnitine plus cilostazol versus cilostazol alone for the treatment of claudication in patients with peripheral artery disease: a multicenter, randomized, double-blind, placebo-controlled trial. Vasc Med. 2012 Jun; 17(3):145-54. PMID: 22615190.
      View in: PubMed
    84. Lala A, Hiatt WR, Berger JS. Aspirin in primary prevention: can we individualize care? Cardiovasc Diagn Ther. 2012 Jun; 2(2):169-72. PMID: 24282710; PMCID: PMC3839141.
    85. Jones WS, Duscha BD, Robbins JL, Duggan NN, Regensteiner JG, Kraus WE, Hiatt WR, Dokun AO, Annex BH. Alteration in angiogenic and anti-angiogenic forms of vascular endothelial growth factor-A in skeletal muscle of patients with intermittent claudication following exercise training. Vasc Med. 2012 Apr; 17(2):94-100. PMID: 22402934; PMCID: PMC3609421.
    86. Hiatt WR, Thomas A, Goldfine AB. What cost weight loss? Circulation. 2012 Mar 06; 125(9):1171-7. PMID: 22392864.
      View in: PubMed
    87. Hirsch AT, Allison MA, Gomes AS, Corriere MA, Duval S, Ershow AG, Hiatt WR, Karas RH, Lovell MB, McDermott MM, Mendes DM, Nussmeier NA, Treat-Jacobson D. A call to action: women and peripheral artery disease: a scientific statement from the American Heart Association. Circulation. 2012 Mar 20; 125(11):1449-72. PMID: 22343782.
      View in: PubMed
    88. Mohler ER, Bundens W, Denenberg J, Medenilla E, Hiatt WR, Criqui MH. Progression of asymptomatic peripheral artery disease over 1 year. Vasc Med. 2012 Feb; 17(1):10-6. PMID: 22363014.
      View in: PubMed
    89. Violi F, Basili S, Berger JS, Hiatt WR. Antiplatelet therapy in peripheral artery disease. Handb Exp Pharmacol. 2012; (210):547-63. PMID: 22918746.
      View in: PubMed
    90. Brass EP, Cooper LT, Morgan RE, Hiatt WR. A phase II dose-ranging study of the phosphodiesterase inhibitor K-134 in patients with peripheral artery disease and claudication. J Vasc Surg. 2012 Feb; 55(2):381-389.e1. PMID: 22119244.
      View in: PubMed
    91. Duscha BD, Robbins JL, Jones WS, Kraus WE, Lye RJ, Sanders JM, Allen JD, Regensteiner JG, Hiatt WR, Annex BH. Angiogenesis in skeletal muscle precede improvements in peak oxygen uptake in peripheral artery disease patients. Arterioscler Thromb Vasc Biol. 2011 Nov; 31(11):2742-8. PMID: 21868709; PMCID: PMC3578302.
    92. Creager MA, Olin JW, Belch JJ, Moneta GL, Henry TD, Rajagopalan S, Annex BH, Hiatt WR. Effect of hypoxia-inducible factor-1alpha gene therapy on walking performance in patients with intermittent claudication. Circulation. 2011 Oct 18; 124(16):1765-73. PMID: 21947297.
      View in: PubMed
    93. Brass EP, Hiatt WR. Improving the FDA's advisory committee process. J Clin Pharmacol. 2012 Aug; 52(8):1277-83. PMID: 21908879.
      View in: PubMed
    94. Hiatt WR. Commentary. The fate of the claudicant--a prospective study of 1969 claudicants. Eur J Vasc Endovasc Surg. 2011 Sep; 42 Suppl 1:S7-8. PMID: 21855027.
      View in: PubMed
    95. Goldfine AB, Kaul S, Hiatt WR. Fibrates in the treatment of dyslipidemias--time for a reassessment. N Engl J Med. 2011 Aug 11; 365(6):481-4. PMID: 21830963.
      View in: PubMed
    96. Berger JS, Lala A, Krantz MJ, Baker GS, Hiatt WR. Aspirin for the prevention of cardiovascular events in patients without clinical cardiovascular disease: a meta-analysis of randomized trials. Am Heart J. 2011 Jul; 162(1):115-24.e2. PMID: 21742097.
      View in: PubMed
    97. Dhangana R, Murphy TP, Coll JR, Ahn SH, Zafar AM, Qadeer FF, Hiatt WR. Prevalence of abnormal ankle-brachial index among individuals with low or intermediate Framingham Risk Scores. J Vasc Interv Radiol. 2011 Aug; 22(8):1077-82. PMID: 21705232.
      View in: PubMed
    98. Van Belle E, Nikol S, Norgren L, Baumgartner I, Driver V, Hiatt WR, Belch J. Insights on the role of diabetes and geographic variation in patients with critical limb ischaemia. Eur J Vasc Endovasc Surg. 2011 Sep; 42(3):365-73. PMID: 21696982.
      View in: PubMed
    99. Yan BP, Lau JY, Yu CM, Au K, Chan KW, Yu DS, Ma RC, Lam YY, Hiatt WR. Chinese translation and validation of the Walking Impairment Questionnaire in patients with peripheral artery disease. Vasc Med. 2011 Jun; 16(3):167-72. PMID: 21636675.
      View in: PubMed
    100. Belch J, Hiatt WR, Baumgartner I, Driver IV, Nikol S, Norgren L, Van Belle E. Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemia. Lancet. 2011 Jun 04; 377(9781):1929-37. PMID: 21621834.
      View in: PubMed
    101. Lewis RJ, Connor JT, Teerlink JR, Murphy JR, Cooper LT, Hiatt WR, Brass EP. Application of adaptive design and decision making to a phase II trial of a phosphodiesterase inhibitor for the treatment of intermittent claudication. Trials. 2011 May 25; 12:134. PMID: 21612611; PMCID: PMC3126735.
    102. Robbins JL, Jones WS, Duscha BD, Allen JD, Kraus WE, Regensteiner JG, Hiatt WR, Annex BH. Relationship between leg muscle capillary density and peak hyperemic blood flow with endurance capacity in peripheral artery disease. J Appl Physiol (1985). 2011 Jul; 111(1):81-6. PMID: 21512146; PMCID: PMC3137528.
    103. Hiatt WR, Creager MA, Amato A, Brass EP. Effect of propionyl-L-carnitine on a background of monitored exercise in patients with claudication secondary to peripheral artery disease. J Cardiopulm Rehabil Prev. 2011 Mar-Apr; 31(2):125-32. PMID: 20861750.
      View in: PubMed
    104. Mays RJ, Casserly IP, Kohrt WM, Ho PM, Hiatt WR, Nehler MR, Regensteiner JG. Assessment of functional status and quality of life in claudication. J Vasc Surg. 2011 May; 53(5):1410-21. PMID: 21334172; PMCID: PMC3541824.
    105. Goldenberg NA, Spyropoulos AC, Halperin JL, Kessler CM, Schulman S, Turpie AG, Skene AM, Cutler NR, Hiatt WR. Improving academic leadership and oversight in large industry-sponsored clinical trials: the ARO-CRO model. Blood. 2011 Feb 17; 117(7):2089-92. PMID: 21068436; PMCID: PMC3062324.
    106. Brevetti G, Giugliano G, Brevetti L, Hiatt WR. Inflammation in peripheral artery disease. Circulation. 2010 Nov 02; 122(18):1862-75. PMID: 21041698.
      View in: PubMed
    107. Belch JJ, Dormandy J, Biasi GM, Biasi BM, Cairols M, Diehm C, Eikelboom B, Golledge J, Jawien A, Lepäntalo M, Norgren L, Hiatt WR, Becquemin JP, Bergqvist D, Clement D, Baumgartner I, Minar E, Stonebridge P, Vermassen F, Matyas L, Leizorovicz A. Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial. J Vasc Surg. 2010 Oct; 52(4):825-33, 833.e1-2. PMID: 20678878.
      View in: PubMed
    108. Norgren L, Hiatt WR, Dormandy JA, Hirsch AT, Jaff MR, Diehm C, Baumgartner I, Belch JJ. The next 10 years in the management of peripheral artery disease: perspectives from the 'PAD 2009' Conference. Eur J Vasc Endovasc Surg. 2010 Sep; 40(3):375-80. PMID: 20554459.
      View in: PubMed
    109. Pande RL, Hiatt WR, Zhang P, Hittel N, Creager MA. A pooled analysis of the durability and predictors of treatment response of cilostazol in patients with intermittent claudication. Vasc Med. 2010 Jun; 15(3):181-8. PMID: 20385711; PMCID: PMC2883185.
    110. Hiatt WR, Hirsch AT, Creager MA, Rajagopalan S, Mohler ER, Ballantyne CM, Regensteiner JG, Treat-Jacobson D, Dale RA, Rooke T. Effect of niacin ER/lovastatin on claudication symptoms in patients with peripheral artery disease. Vasc Med. 2010 Jun; 15(3):171-9. PMID: 20212073.
      View in: PubMed
    111. Krantz MJ, Berger JS, Hiatt WR. An aspirin a day: are we barking up the wrong willow tree? Pharmacotherapy. 2010 Feb; 30(2):115-8. PMID: 20099985.
      View in: PubMed
    112. Goldenberg NA, Tripputi M, Crowther M, Abshire TC, DiMichele D, Manco-Johnson MJ, Hiatt WR. The "parallel-cohort RCT": Novel design aspects and application in the Kids-DOTT trial of pediatric venous thromboembolism. Contemp Clin Trials. 2010 Jan; 31(1):131-3. PMID: 19941974.
      View in: PubMed
    113. Aronow H, Hiatt WR. The burden of peripheral artery disease and the role of antiplatelet therapy. Postgrad Med. 2009 Jul; 121(4):123-35. PMID: 19641278.
      View in: PubMed
    114. Shah AP, Klein AJ, Sterrett A, Messenger JC, Albert S, Nehler MR, Hiatt WR, Casserly IP. Clinical outcomes using aggressive approach to anatomic screening and endovascular revascularization in a veterans affairs population with critical limb ischemia. Catheter Cardiovasc Interv. 2009 Jul 01; 74(1):11-9. PMID: 19360870.
      View in: PubMed
    115. Berger JS, Krantz MJ, Kittelson JM, Hiatt WR. Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials. JAMA. 2009 May 13; 301(18):1909-19. PMID: 19436018.
      View in: PubMed
    116. Jaff MR, Dale RA, Creager MA, Lipicky RJ, Constant J, Campbell LA, Hiatt WR. Anti-chlamydial antibiotic therapy for symptom improvement in peripheral artery disease: prospective evaluation of rifalazil effect on vascular symptoms of intermittent claudication and other endpoints in Chlamydia pneumoniae seropositive patients (PROVIDENCE-1). Circulation. 2009 Jan 27; 119(3):452-8. PMID: 19139383.
      View in: PubMed
    117. Hiatt WR, Goldstone J, Smith SC, McDermott M, Moneta G, Oka R, Newman AB, Pearce WH. Atherosclerotic Peripheral Vascular Disease Symposium II: nomenclature for vascular diseases. Circulation. 2008 Dec 16; 118(25):2826-9. PMID: 19106403.
      View in: PubMed
    118. Creager MA, White CJ, Hiatt WR, Criqui MH, Josephs SC, Alberts MJ, Pearce WH, Gray BH, Rocha-Singh KJ. Atherosclerotic Peripheral Vascular Disease Symposium II: executive summary. Circulation. 2008 Dec 16; 118(25):2811-25. PMID: 19106402.
      View in: PubMed
    119. Bristow MR, Hiatt WR. The FDA regulatory process for drug and genetic diagnostic test approvals. Clin Transl Sci. 2008 Dec; 1(3):188-9. PMID: 20443847.
      View in: PubMed
    120. Hiatt WR. Can measuring the ankle-brachial index improve public health? J Am Coll Cardiol. 2008 Nov 18; 52(21):1743-4. PMID: 19007696.
      View in: PubMed
    121. Espeland MA, Regensteiner JG, Jaramillo SA, Gregg E, Knowler WC, Wagenknecht LE, Bahnson J, Haffner S, Hill J, Hiatt WR. Measurement characteristics of the ankle-brachial index: results from the Action for Health in Diabetes study. Vasc Med. 2008 Aug; 13(3):225-33. PMID: 18687759.
      View in: PubMed
    122. Fowkes FG, Murray GD, Butcher I, Heald CL, Lee RJ, Chambless LE, Folsom AR, Hirsch AT, Dramaix M, deBacker G, Wautrecht JC, Kornitzer M, Newman AB, Cushman M, Sutton-Tyrrell K, Fowkes FG, Lee AJ, Price JF, d'Agostino RB, Murabito JM, Norman PE, Jamrozik K, Curb JD, Masaki KH, Rodríguez BL, Dekker JM, Bouter LM, Heine RJ, Nijpels G, Stehouwer CD, Ferrucci L, McDermott MM, Stoffers HE, Hooi JD, Knottnerus JA, Ogren M, Hedblad B, Witteman JC, Breteler MM, Hunink MG, Hofman A, Criqui MH, Langer RD, Fronek A, Hiatt WR, Hamman R, Resnick HE, Guralnik J, McDermott MM. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA. 2008 Jul 09; 300(2):197-208. PMID: 18612117; PMCID: PMC2932628.
    123. Hiatt WR, Lincoff AM, Harrington RA. Acute pharmacological conversion of atrial fibrillation to sinus rhythm: is short-term symptomatic therapy worth it? A report from the December 2007 Meeting of the Cardiovascular and Renal Drugs Advisory Committee of the Food and Drug Administration. Circulation. 2008 Jun 03; 117(22):2956-7. PMID: 18519863.
      View in: PubMed
    124. Rueda CA, Nehler MR, Perry DJ, McLafferty RB, Casserly IP, Hiatt WR, Peyton BD. Patterns of artery disease in 450 patients undergoing revascularization for critical limb ischemia: implications for clinical trial design. J Vasc Surg. 2008 May; 47(5):995-9; discussion 999-1000. PMID: 18372151.
      View in: PubMed
    125. Allison MA, Hiatt WR, Hirsch AT, Coll JR, Criqui MH. A high ankle-brachial index is associated with increased cardiovascular disease morbidity and lower quality of life. J Am Coll Cardiol. 2008 Apr 01; 51(13):1292-8. PMID: 18371562.
      View in: PubMed
    126. Regensteiner JG, Hiatt WR, Coll JR, Criqui MH, Treat-Jacobson D, McDermott MM, Hirsch AT. The impact of peripheral arterial disease on health-related quality of life in the Peripheral Arterial Disease Awareness, Risk, and Treatment: New Resources for Survival (PARTNERS) Program. Vasc Med. 2008 Feb; 13(1):15-24. PMID: 18372434.
      View in: PubMed
    127. Creager MA, Pande RL, Hiatt WR. A randomized trial of iloprost in patients with intermittent claudication. Vasc Med. 2008 Feb; 13(1):5-13. PMID: 18372433.
      View in: PubMed
    128. Hiatt WR, Money SR, Brass EP. Long-term safety of cilostazol in patients with peripheral artery disease: the CASTLE study (Cilostazol: A Study in Long-term Effects). J Vasc Surg. 2008 Feb; 47(2):330-336. PMID: 18155871.
      View in: PubMed
    129. Norgren L, Hiatt WR. Why TASC II? Vasc Med. 2007 Nov; 12(4):327. PMID: 18048470.
      View in: PubMed
    130. Haugen S, Casserly IP, Regensteiner JG, Hiatt WR. Risk assessment in the patient with established peripheral arterial disease. Vasc Med. 2007 Nov; 12(4):343-50. PMID: 18048472.
      View in: PubMed
    131. Mitchell RG, Duscha BD, Robbins JL, Redfern SI, Chung J, Bensimhon DR, Kraus WE, Hiatt WR, Regensteiner JG, Annex BH. Increased levels of apoptosis in gastrocnemius skeletal muscle in patients with peripheral arterial disease. Vasc Med. 2007 Nov; 12(4):285-90. PMID: 18048464.
      View in: PubMed
    132. Sommerfield T, Price J, Hiatt WR. Omega-3 fatty acids for intermittent claudication. Cochrane Database Syst Rev. 2007 Oct 17; (4):CD003833. PMID: 17943801.
      View in: PubMed
    133. Norgren L, Hiatt WR, Harris KA, Lammer J. TASC II section F on revascularization in PAD. J Endovasc Ther. 2007 Oct; 14(5):743-4. PMID: 17924742.
      View in: PubMed
    134. Schrier RW, Estacio RO, Mehler PS, Hiatt WR. Appropriate blood pressure control in hypertensive and normotensive type 2 diabetes mellitus: a summary of the ABCD trial. Nat Clin Pract Nephrol. 2007 Aug; 3(8):428-38. PMID: 17653121.
      View in: PubMed
    135. Violi F, Hiatt W. A critical review of antiplatelet treatment in peripheral arterial disease. Intern Emerg Med. 2007 Jun; 2(2):84-7. PMID: 17634816.
      View in: PubMed
    136. Chung J, Brass EP, Ulrich RG, Hiatt WR. Effect of atorvastatin on energy expenditure and skeletal muscle oxidative metabolism at rest and during exercise. Clin Pharmacol Ther. 2008 Feb; 83(2):243-50. PMID: 17554242.
      View in: PubMed
    137. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG, Rutherford RB. Inter-society consensus for the management of peripheral arterial disease. Int Angiol. 2007 Jun; 26(2):81-157. PMID: 17489079.
      View in: PubMed
    138. Brass EP, Jiao J, Hiatt W. Optimal assessment of baseline treadmill walking performance in claudication clinical trials. Vasc Med. 2007 May; 12(2):97-103. PMID: 17615797.
      View in: PubMed
    139. Hiatt WR, Krantz MJ. The efficacy of aspirin in peripheral arterial disease: an unresolved question. J Mal Vasc. 2007 Apr; 32(2):71-2. PMID: 17382504.
      View in: PubMed
    140. Nehler MR, Brass EP, Anthony R, Dormandy J, Jiao J, McNamara TO, Hiatt WR. Adjunctive parenteral therapy with lipo-ecraprost, a prostaglandin E1 analog, in patients with critical limb ischemia undergoing distal revascularization does not improve 6-month outcomes. J Vasc Surg. 2007 May; 45(5):953-60; discussion 960-1. PMID: 17350216.
      View in: PubMed
    141. Bauer TA, Brass EP, Barstow TJ, Hiatt WR. Skeletal muscle StO2 kinetics are slowed during low work rate calf exercise in peripheral arterial disease. Eur J Appl Physiol. 2007 May; 100(2):143-51. PMID: 17310391.
      View in: PubMed
    142. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg. 2007 Jan; 45 Suppl S:S5-67. PMID: 17223489.
      View in: PubMed
    143. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG, Bell K, Caporusso J, Durand-Zaleski I, Komori K, Lammer J, Liapis C, Novo S, Razavi M, Robbs J, Schaper N, Shigematsu H, Sapoval M, White C, White J, Clement D, Creager M, Jaff M, Mohler E, Rutherford RB, Sheehan P, Sillesen H, Rosenfield K. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg. 2007; 33 Suppl 1:S1-75. PMID: 17140820.
      View in: PubMed
    144. Brass EP, Anthony R, Cobb FR, Koda I, Jiao J, Hiatt WR. The novel phosphodiesterase inhibitor NM-702 improves claudication-limited exercise performance in patients with peripheral arterial disease. J Am Coll Cardiol. 2006 Dec 19; 48(12):2539-45. PMID: 17174195.
      View in: PubMed
    145. Hiatt WR. Observational studies of drug safety--aprotinin and the absence of transparency. N Engl J Med. 2006 Nov 23; 355(21):2171-3. PMID: 17124013.
      View in: PubMed
    146. Hiatt WR. The effects of vascular disease and aging on the regulation of circulating endothelial progenitor cells. Vasc Med. 2006 Nov; 11(4):258. PMID: 17390550.
      View in: PubMed
    147. Brass EP, Hiatt WR. Review of mortality and cardiovascular event rates in patients enrolled in clinical trials for claudication therapies. Vasc Med. 2006 Nov; 11(3):141-5. PMID: 17288119.
      View in: PubMed
    148. Scherer SA, Hiatt WR, Regensteiner JG. Lack of relationship between gait parameters and physical function in peripheral arterial disease. J Vasc Surg. 2006 Oct; 44(4):782-8. PMID: 17012002.
      View in: PubMed
    149. Chung J, Bartelson BB, Hiatt WR, Peyton BD, McLafferty RB, Hopley CW, Salter KD, Nehler MR. Wound healing and functional outcomes after infrainguinal bypass with reversed saphenous vein for critical limb ischemia. J Vasc Surg. 2006 Jun; 43(6):1183-90. PMID: 16765235.
      View in: PubMed
    150. Brass EP, Anthony R, Dormandy J, Hiatt WR, Jiao J, Nakanishi A, McNamara T, Nehler M. Parenteral therapy with lipo-ecraprost, a lipid-based formulation of a PGE1 analog, does not alter six-month outcomes in patients with critical leg ischemia. J Vasc Surg. 2006 Apr; 43(4):752-9. PMID: 16616232.
      View in: PubMed
    151. Hiatt WR, Nissen SE. New drug application 21-628, Certican (everolimus), for the proposed indication of prophylaxis of rejection in heart transplantation: report from the Cardiovascular and Renal Drugs Advisory Committee, US Food and Drug Administration, November 16, 2005, Rockville, Md. Circulation. 2006 Mar 14; 113(10):e394-5. PMID: 16534016.
      View in: PubMed
    152. Brass EP, Lewis RJ, Lipicky R, Murphy J, Hiatt WR. Risk assessment in drug development for symptomatic indications: a framework for the prospective exclusion of unacceptable cardiovascular risk. Clin Pharmacol Ther. 2006 Mar; 79(3):165-72. PMID: 16513441.
      View in: PubMed
    153. Marso SP, Hiatt WR. Peripheral arterial disease in patients with diabetes. J Am Coll Cardiol. 2006 Mar 07; 47(5):921-9. PMID: 16516072.
      View in: PubMed
    154. Hiatt WR, Krantz MJ. Masterclass series in peripheral arterial disease. Antiplatelet therapy for peripheral arterial disease and claudication. Vasc Med. 2006 Feb; 11(1):55-60. PMID: 16669416.
      View in: PubMed
    155. Krantz MJ, Coronel SM, Hiatt WR. Use of ankle brachial index screening for selecting patients for antiplatelet drug therapy. Pharmacotherapy. 2005 Dec; 25(12):1826-8; discussion 1827-8. PMID: 16305303.
      View in: PubMed
    156. Mehler PS, Krantz MJ, Lundgren RA, Estacio RO, MacKenzie TD, Petralia L, Hiatt WR. Bridging the quality gap in diabetic hyperlipidemia: a practice-based intervention. Am J Med. 2005 Dec; 118(12):1414. PMID: 16378790.
      View in: PubMed
    157. Fletcher B, Berra K, Ades P, Braun LT, Burke LE, Durstine JL, Fair JM, Fletcher GF, Goff D, Hayman LL, Hiatt WR, Miller NH, Krauss R, Kris-Etherton P, Stone N, Wilterdink J, Winston M. Managing abnormal blood lipids: a collaborative approach. Circulation. 2005 Nov 15; 112(20):3184-209. PMID: 16286609.
      View in: PubMed
    158. Hiatt WR. The US experience with cilostazol in treating intermittent claudication. Atheroscler Suppl. 2005 Dec 15; 6(4):21-31. PMID: 16275166.
      View in: PubMed
    159. Hiatt WR, Cox L, Greenwalt M, Griffin A, Schechter C. Quality of the assessment of primary and secondary endpoints in claudication and critical leg ischemia trials. Vasc Med. 2005 Aug; 10(3):207-13. PMID: 16235774.
      View in: PubMed
    160. Hiatt WR. Carnitine and peripheral arterial disease. Ann N Y Acad Sci. 2004 Nov; 1033:92-8. PMID: 15591006.
      View in: PubMed
    161. Hiatt WR, Klepack E, Nehler M, Regensteiner JG, Blue J, Imus J, Criqui MH. The effect of inhibition of acyl coenzyme A-cholesterol acyltransferase (ACAT) on exercise performance in patients with peripheral arterial disease. Vasc Med. 2004 Nov; 9(4):271-7. PMID: 15678619.
      View in: PubMed
    162. Mohler ER, Treat-Jacobson D, Reilly MP, Cunningham KE, Miani M, Criqui MH, Hiatt WR, Hirsch AT. Utility and barriers to performance of the ankle-brachial index in primary care practice. Vasc Med. 2004 Nov; 9(4):253-60. PMID: 15678616.
      View in: PubMed
    163. Brass EP, Hiatt WR, Green S. Skeletal muscle metabolic changes in peripheral arterial disease contribute to exercise intolerance: a point-counterpoint discussion. Vasc Med. 2004 Nov; 9(4):293-301. PMID: 15678622.
      View in: PubMed
    164. Hiatt WR. Treatment of disability in peripheral arterial disease: new drugs. Curr Drug Targets Cardiovasc Haematol Disord. 2004 Sep; 4(3):227-31. PMID: 15379614.
      View in: PubMed
    165. Bauer TA, Brass EP, Hiatt WR. Impaired muscle oxygen use at onset of exercise in peripheral arterial disease. J Vasc Surg. 2004 Sep; 40(3):488-93. PMID: 15337878.
      View in: PubMed
    166. Faxon DP, Fuster V, Libby P, Beckman JA, Hiatt WR, Thompson RW, Topper JN, Annex BH, Rundback JH, Fabunmi RP, Robertson RM, Loscalzo J. Atherosclerotic Vascular Disease Conference: Writing Group III: pathophysiology. Circulation. 2004 Jun 01; 109(21):2617-25. PMID: 15173044.
      View in: PubMed
    167. Gates PE, Tanaka H, Hiatt WR, Seals DR. Dietary sodium restriction rapidly improves large elastic artery compliance in older adults with systolic hypertension. Hypertension. 2004 Jul; 44(1):35-41. PMID: 15173128.
      View in: PubMed
    168. Rajagopalan S, Olin JW, Young S, Erikson M, Grossman PM, Mendelsohn FO, Regensteiner JG, Hiatt WR, Annex BH. Design of the Del-1 for therapeutic angiogenesis trial (DELTA-1), a phase II multicenter, double-blind, placebo-controlled trial of VLTS-589 in subjects with intermittent claudication secondary to peripheral arterial disease. Hum Gene Ther. 2004 Jun; 15(6):619-24. PMID: 15212720.
      View in: PubMed
    169. Bauer TA, Brass EP, Nehler M, Barstow TJ, Hiatt WR. Pulmonary VO2 dynamics during treadmill and arm exercise in peripheral arterial disease. J Appl Physiol (1985). 2004 Aug; 97(2):627-34. PMID: 15090483.
      View in: PubMed
    170. Hiatt WR. Sounding the PAD alarm. GPs can diagnose peripheral artery disease with a simple ankle-and-arm blood pressure test. Health News. 2004 Apr; 10(4):7. PMID: 15088582.
      View in: PubMed
    171. Hiatt WR, Hirsch AT, Cooke JP, Olin JW, Brater DC, Creager MA. Randomized trial of AT-1015 for treatment of intermittent claudication. A novel 5-hydroxytryptamine antagonist with no evidence of efficacy. Vasc Med. 2004 Feb; 9(1):18-25. PMID: 15230484.
      View in: PubMed
    172. Sommerfield T, Hiatt WR. Omega-3 fatty acids for intermittent claudication. Cochrane Database Syst Rev. 2004; (3):CD003833. PMID: 15266504.
      View in: PubMed
    173. Mohler ER, Hiatt WR, Creager MA. Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease. Circulation. 2003 Sep 23; 108(12):1481-6. PMID: 12952839.
      View in: PubMed
    174. Coyne KS, Margolis MK, Gilchrist KA, Grandy SP, Hiatt WR, Ratchford A, Revicki DA, Weintraub WS, Regensteiner JG. Evaluating effects of method of administration on Walking Impairment Questionnaire. J Vasc Surg. 2003 Aug; 38(2):296-304. PMID: 12891111.
      View in: PubMed
    175. Nehler MR, Coll JR, Hiatt WR, Regensteiner JG, Schnickel GT, Klenke WA, Strecker PK, Anderson MW, Jones DN, Whitehill TA, Moskowitz S, Krupski WC. Functional outcome in a contemporary series of major lower extremity amputations. J Vasc Surg. 2003 Jul; 38(1):7-14. PMID: 12844082.
      View in: PubMed
    176. Mohler ER, Hiatt WR, Olin JW, Wade M, Jeffs R, Hirsch AT. Treatment of intermittent claudication with beraprost sodium, an orally active prostaglandin I2 analogue: a double-blinded, randomized, controlled trial. J Am Coll Cardiol. 2003 May 21; 41(10):1679-86. PMID: 12767646.
      View in: PubMed
    177. Falcone RA, Hirsch AT, Regensteiner JG, Treat-Jacobson D, Williams MA, Hiatt WR, Stewart KJ. Peripheral arterial disease rehabilitation: a review. J Cardiopulm Rehabil. 2003 May-Jun; 23(3):170-5. PMID: 12782899.
      View in: PubMed
    178. Mehler PS, Esler A, Estacio RO, MacKenzie TD, Hiatt WR, Schrier RW. Lack of improvement in the treatment of hyperlipidemia among patients with type 2 diabetes. Am J Med. 2003 Apr 01; 114(5):377-82. PMID: 12714127.
      View in: PubMed
    179. Nehler MR, Hiatt WR, Taylor LM. Is revascularization and limb salvage always the best treatment for critical limb ischemia? J Vasc Surg. 2003 Mar; 37(3):704-8. PMID: 12618724.
      View in: PubMed
    180. Mehler PS, Coll JR, Estacio R, Esler A, Schrier RW, Hiatt WR. Intensive blood pressure control reduces the risk of cardiovascular events in patients with peripheral arterial disease and type 2 diabetes. Circulation. 2003 Feb 11; 107(5):753-6. PMID: 12578880.
      View in: PubMed
    181. Alving BM, Francis CW, Hiatt WR, Jackson MR. Consultations on patients with venous or arterial diseases. Hematology Am Soc Hematol Educ Program. 2003; 540-58. PMID: 14633798.
      View in: PubMed
    182. Stewart KJ, Hiatt WR, Regensteiner JG, Hirsch AT. Exercise training for claudication. N Engl J Med. 2002 Dec 12; 347(24):1941-51. PMID: 12477945.
      View in: PubMed
    183. Hiatt WR. Pharmacologic therapy for peripheral arterial disease and claudication. J Vasc Surg. 2002 Dec; 36(6):1283-91. PMID: 12469066.
      View in: PubMed
    184. Regensteiner JG, Ware JE, McCarthy WJ, Zhang P, Forbes WP, Heckman J, Hiatt WR. Effect of cilostazol on treadmill walking, community-based walking ability, and health-related quality of life in patients with intermittent claudication due to peripheral arterial disease: meta-analysis of six randomized controlled trials. J Am Geriatr Soc. 2002 Dec; 50(12):1939-46. PMID: 12473004.
      View in: PubMed
    185. Swenson CJ, Trepka MJ, Rewers MJ, Scarbro S, Hiatt WR, Hamman RF. Cardiovascular disease mortality in Hispanics and non-Hispanic whites. Am J Epidemiol. 2002 Nov 15; 156(10):919-28. PMID: 12419764.
      View in: PubMed
    186. Brass EP, Adler S, Sietsema KE, Amato A, Esler A, Hiatt WR. Peripheral arterial disease is not associated with an increased prevalence of intradialytic cramps in patients on maintenance hemodialysis. Am J Nephrol. 2002 Sep-Dec; 22(5-6):491-6. PMID: 12381949.
      View in: PubMed
    187. Hiatt WR. Abciximab added to urokinase increased amputation-free survival in peripheral arterial occlusion of the legs. ACP J Club. 2002 Jul-Aug; 137(1):12. PMID: 12093211.
      View in: PubMed
    188. Hiatt WR. Preventing atherothrombotic events in peripheral arterial disease: the use of antiplatelet therapy. J Intern Med. 2002 Mar; 251(3):193-206. PMID: 11886478.
      View in: PubMed
    189. Regensteiner JG, Hiatt WR. Current medical therapies for patients with peripheral arterial disease: a critical review. Am J Med. 2002 Jan; 112(1):49-57. PMID: 11812407.
      View in: PubMed
    190. Dawson DL, Hiatt WR, Creager M, Hirsch AT. Peripheral arterial disease: medical care and prevention of complications. Prev Cardiol. 2002; 5(3):119-30. PMID: 12091754.
      View in: PubMed
    191. Regensteiner JG, Hiatt WR. Treatment of peripheral arterial disease. Clin Cornerstone. 2002; 4(5):26-40. PMID: 12425182.
      View in: PubMed
    192. Sietsema KE, Hiatt WR, Esler A, Adler S, Amato A, Brass EP. Clinical and demographic predictors of exercise capacity in end-stage renal disease. Am J Kidney Dis. 2002 Jan; 39(1):76-85. PMID: 11774105.
      View in: PubMed
    193. Cooper LT, Hiatt WR, Creager MA, Regensteiner JG, Casscells W, Isner JM, Cooke JP, Hirsch AT. Proteinuria in a placebo-controlled study of basic fibroblast growth factor for intermittent claudication. Vasc Med. 2001 Nov; 6(4):235-9. PMID: 11958389.
      View in: PubMed
    194. Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager MA, Olin JW, Krook SH, Hunninghake DB, Comerota AJ, Walsh ME, McDermott MM, Hiatt WR. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001 Sep 19; 286(11):1317-24. PMID: 11560536.
      View in: PubMed
    195. Seals DR, Tanaka H, Clevenger CM, Monahan KD, Reiling MJ, Hiatt WR, Davy KP, DeSouza CA. Blood pressure reductions with exercise and sodium restriction in postmenopausal women with elevated systolic pressure: role of arterial stiffness. J Am Coll Cardiol. 2001 Aug; 38(2):506-13. PMID: 11499745.
      View in: PubMed
    196. Lederman RJ, Tenaglia AN, Anderson RD, Hermiller JB, Rocha-Singh K, Mendelsohn FO, Hiatt WR, Moon T, Whitehouse MJ, Annex BH. Design of the therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (TRAFFIC) trial. Am J Cardiol. 2001 Jul 15; 88(2):192-5, A6-7. PMID: 11448424.
      View in: PubMed
    197. Hiatt WR, Regensteiner JG, Creager MA, Hirsch AT, Cooke JP, Olin JW, Gorbunov GN, Isner J, Lukjanov YV, Tsitsiashvili MS, Zabelskaya TF, Amato A. Propionyl-L-carnitine improves exercise performance and functional status in patients with claudication. Am J Med. 2001 Jun 01; 110(8):616-22. PMID: 11382369.
      View in: PubMed
    198. Hiatt WR. Medical treatment of peripheral arterial disease and claudication. N Engl J Med. 2001 May 24; 344(21):1608-21. PMID: 11372014.
      View in: PubMed
    199. Brass EP, Adler S, Sietsema KE, Hiatt WR, Orlando AM, Amato A. Intravenous L-carnitine increases plasma carnitine, reduces fatigue, and may preserve exercise capacity in hemodialysis patients. Am J Kidney Dis. 2001 May; 37(5):1018-28. PMID: 11325685.
      View in: PubMed
    200. Mehler PS, Scott JY, Pines I, Gifford N, Biggerstaff S, Hiatt WR. Russian immigrant cardiovascular risk assessment. J Health Care Poor Underserved. 2001 May; 12(2):224-35. PMID: 11370189.
      View in: PubMed
    201. Hiatt WR. New treatment options in intermittent claudication: the US experience. Int J Clin Pract Suppl. 2001 Apr; (119):20-7. PMID: 11355276.
      View in: PubMed
    202. Brass EP, Hiatt WR, Gardner AW, Hoppel CL. Decreased NADH dehydrogenase and ubiquinol-cytochrome c oxidoreductase in peripheral arterial disease. Am J Physiol Heart Circ Physiol. 2001 Feb; 280(2):H603-9. PMID: 11158957.
      View in: PubMed
    203. Hiatt WR, Nehler MR. Peripheral arterial disease. Adv Intern Med. 2001; 47:89-110. PMID: 11795081.
      View in: PubMed
    204. Hirsch AT, Hiatt WR. PAD awareness, risk, and treatment: new resources for survival--the USA PARTNERS program. Vasc Med. 2001; 6(3 Suppl):9-12. PMID: 11789964.
      View in: PubMed
    205. McDaniel MD, Nehler MR, Santilli SM, Hiatt WR, Regensteiner JG, Goldstone J, McCarthy WJ, White JV. Extended outcome assessment in the care of vascular diseases: revising the paradigm for the 21st century. Ad Hoc Committee to Study Outcomes Assessment, Society for Vascular Surgery/International Society for Cardiovascular Surgery, North American Chapter. J Vasc Surg. 2000 Dec; 32(6):1239-50. PMID: 11107103.
      View in: PubMed
    206. Dawson DL, Cutler BS, Hiatt WR, Hobson RW, Martin JD, Bortey EB, Forbes WP, Strandness DE. A comparison of cilostazol and pentoxifylline for treating intermittent claudication. Am J Med. 2000 Nov; 109(7):523-30. PMID: 11063952.
      View in: PubMed
    207. Hiatt WR. Regarding: "Expression of myosin heavy chain isoforms in skeletal muscle of patients with peripheral arterial occlusive disease". J Vasc Surg. 2000 Mar; 31(3):611-2. PMID: 10709078.
      View in: PubMed
    208. Krupski WC, Nehler MR, Whitehill TA, Lawson RC, Strecker PK, Hiatt WR. Negative impact of cardiac evaluation before vascular surgery. Vasc Med. 2000; 5(1):3-9. PMID: 10737150.
      View in: PubMed
    209. Brass EP, Hiatt WR. Acquired skeletal muscle metabolic myopathy in atherosclerotic peripheral arterial disease. Vasc Med. 2000; 5(1):55-9. PMID: 10737157.
      View in: PubMed
    210. Brass EP, Wang H, Hiatt WR. Multiple skeletal muscle mitochondrial DNA deletions in patients with unilateral peripheral arterial disease. Vasc Med. 2000; 5(4):225-30. PMID: 11213234.
      View in: PubMed
    211. Hiatt WR. Functional assessment of the claudicant importance of treatment and follow-up strategies. Minerva Cardioangiol. 1999 Nov; 47(11):385-6. PMID: 10641407.
      View in: PubMed
    212. Labs KH, Dormandy JA, Jaeger KA, Stuerzebecher CS, Hiatt WR. Transatlantic Conference on Clinical Trial Guidelines in Peripheral Arterial Disease: clinical trial methodology. Basel PAD Clinical Trial Methodology Group. Circulation. 1999 Oct 26; 100(17):e75-81. PMID: 10534475.
      View in: PubMed
    213. Brandenburg SL, Reusch JE, Bauer TA, Jeffers BW, Hiatt WR, Regensteiner JG. Effects of exercise training on oxygen uptake kinetic responses in women with type 2 diabetes. Diabetes Care. 1999 Oct; 22(10):1640-6. PMID: 10526728.
      View in: PubMed
    214. Hiatt WR. Intermittent claudication revisited: the value of medical therapy. Arch Intern Med. 1999 Sep 13; 159(16):1955-6. PMID: 10493329.
      View in: PubMed
    215. Labs KH, Dormandy JA, Jaeger KA, Stuerzebecher C, Hiatt WR. Trans-atlantic conference on clinical trial guidelines in PAOD (Peripheral arterial occlusive disease) clinical trial methodology. Eur J Vasc Endovasc Surg. 1999 Sep; 18(3):253-65. PMID: 10480800.
      View in: PubMed
    216. Nehler MR, Whitehill TA, Bowers SP, Jones DN, Hiatt WR, Rutherford RB, Krupski WC. Intermediate-term outcome of primary digit amputations in patients with diabetes mellitus who have forefoot sepsis requiring hospitalization and presumed adequate circulatory status. J Vasc Surg. 1999 Sep; 30(3):509-17. PMID: 10477644.
      View in: PubMed
    217. Bauer TA, Regensteiner JG, Brass EP, Hiatt WR. Oxygen uptake kinetics during exercise are slowed in patients with peripheral arterial disease. J Appl Physiol (1985). 1999 Aug; 87(2):809-16. PMID: 10444643.
      View in: PubMed
    218. Wang H, Hiatt WR, Barstow TJ, Brass EP. Relationships between muscle mitochondrial DNA content, mitochondrial enzyme activity and oxidative capacity in man: alterations with disease. Eur J Appl Physiol Occup Physiol. 1999 Jun; 80(1):22-7. PMID: 10367719.
      View in: PubMed
    219. Bhat HK, Hiatt WR, Hoppel CL, Brass EP. Skeletal muscle mitochondrial DNA injury in patients with unilateral peripheral arterial disease. Circulation. 1999 Feb 16; 99(6):807-12. PMID: 9989967.
      View in: PubMed
    220. Nehler MR, Hiatt WR. Exercise therapy for claudication. Ann Vasc Surg. 1999 Jan; 13(1):109-14. PMID: 9878665.
      View in: PubMed
    221. Labs KH, Nehler MR, Roessner M, Jaeger KA, Hiatt WR. Reliability of treadmill testing in peripheral arterial disease: a comparison of a constant load with a graded load treadmill protocol. Vasc Med. 1999; 4(4):239-46. PMID: 10613628.
      View in: PubMed
    222. Regensteiner JG, Bauer TA, Reusch JE, Brandenburg SL, Sippel JM, Vogelsong AM, Smith S, Wolfel EE, Eckel RH, Hiatt WR. Abnormal oxygen uptake kinetic responses in women with type II diabetes mellitus. J Appl Physiol (1985). 1998 Jul; 85(1):310-7. PMID: 9655791.
      View in: PubMed
    223. Brass EP, Hiatt WR. The role of carnitine and carnitine supplementation during exercise in man and in individuals with special needs. J Am Coll Nutr. 1998 Jun; 17(3):207-15. PMID: 9627906.
      View in: PubMed
    224. Scherer SA, Bainbridge JS, Hiatt WR, Regensteiner JG. Gait characteristics of patients with claudication. Arch Phys Med Rehabil. 1998 May; 79(5):529-31. PMID: 9596393.
      View in: PubMed
    225. Estacio RO, Jeffers BW, Hiatt WR, Biggerstaff SL, Gifford N, Schrier RW. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension. N Engl J Med. 1998 Mar 05; 338(10):645-52. PMID: 9486993.
      View in: PubMed
    226. Hiatt WR. Quality of life assessment in peripheral arterial disease. Atherosclerosis. 1997 Jun; 131 Suppl:S35-6. PMID: 9253476.
      View in: PubMed
    227. Regensteiner JG, Meyer TJ, Krupski WC, Cranford LS, Hiatt WR. Hospital vs home-based exercise rehabilitation for patients with peripheral arterial occlusive disease. Angiology. 1997 Apr; 48(4):291-300. PMID: 9112877.
      View in: PubMed
    228. Regensteiner JG, Gardner A, Hiatt WR. Exercise testing and exercise rehabilitation for patients with peripheral arterial disease: status in 1997. Vasc Med. 1997; 2(2):147-55. PMID: 9546957.
      View in: PubMed
    229. Hiatt WR. Current and future drug therapies for claudication. Vasc Med. 1997; 2(3):257-62. PMID: 9546977.
      View in: PubMed
    230. Hiatt WR, Regensteiner JG, Wolfel EE, Carry MR, Brass EP. Effect of exercise training on skeletal muscle histology and metabolism in peripheral arterial disease. J Appl Physiol (1985). 1996 Aug; 81(2):780-8. PMID: 8872646.
      View in: PubMed
    231. Hiatt WR, Creager MA, Cooke JP, Hirsch AT. Building a partnership between vascular medicine and vascular surgery: a coalition for the future of vascular care. J Vasc Surg. 1996 May; 23(5):918-25. PMID: 8667517.
      View in: PubMed
    232. Hirsch AT, Haidet G, Creager MA, Hiatt WR, Regensteiner JG, Cooke JP. Exercise rehabilitation for treatment of claudication. JAMA. 1996 Feb 21; 275(7):519-20. PMID: 8606471.
      View in: PubMed
    233. Regensteiner JG, Steiner JF, Hiatt WR. Exercise training improves functional status in patients with peripheral arterial disease. J Vasc Surg. 1996 Jan; 23(1):104-15. PMID: 8558725.
      View in: PubMed
    234. Minkler PE, Brass EP, Hiatt WR, Ingalls ST, Hoppel CL. Quantification of carnitine, acetylcarnitine, and total carnitine in tissues by high-performance liquid chromatography: the effect of exercise on carnitine homeostasis in man. Anal Biochem. 1995 Nov 01; 231(2):315-22. PMID: 8594979.
      View in: PubMed
    235. Hiatt WR, Hirsch AT, Regensteiner JG, Brass EP. Clinical trials for claudication. Assessment of exercise performance, functional status, and clinical end points. Vascular Clinical Trialists. Circulation. 1995 Aug 01; 92(3):614-21. PMID: 7634476.
      View in: PubMed
    236. Regensteiner JG, Sippel J, McFarling ET, Wolfel EE, Hiatt WR. Effects of non-insulin-dependent diabetes on oxygen consumption during treadmill exercise. Med Sci Sports Exerc. 1995 Jun; 27(6):875-81. PMID: 7658949.
      View in: PubMed
    237. Regensteiner JG, Sippel J, McFarling ET, Wolfel EE, Hiatt WR. Effects of non-insulin-dependent diabetes on oxygen consumption during treadmill exercise. Med Sci Sports Exerc. 1995 May; 27(5):661-7. PMID: 7674869.
      View in: PubMed
    238. England JD, Ferguson MA, Hiatt WR, Regensteiner JG. Progression of neuropathy in peripheral arterial disease. Muscle Nerve. 1995 Apr; 18(4):380-7. PMID: 7715622.
      View in: PubMed
    239. Hiatt WR, Hoag S, Hamman RF. Effect of diagnostic criteria on the prevalence of peripheral arterial disease. The San Luis Valley Diabetes Study. Circulation. 1995 Mar 01; 91(5):1472-9. PMID: 7867189.
      View in: PubMed
    240. Regensteiner JG, Hiatt WR. Exercise rehabilitation for patients with peripheral arterial disease. Exerc Sport Sci Rev. 1995; 23:1-24. PMID: 7556347.
      View in: PubMed
    241. Hiatt WR, Wolfel EE, Meier RH, Regensteiner JG. Superiority of treadmill walking exercise versus strength training for patients with peripheral arterial disease. Implications for the mechanism of the training response. Circulation. 1994 Oct; 90(4):1866-74. PMID: 7923674.
      View in: PubMed
    242. Regensteiner JG, Hiatt WR. Medical management of peripheral arterial disease. J Vasc Interv Radiol. 1994 Sep-Oct; 5(5):669-77. PMID: 8000114.
      View in: PubMed
    243. Hiatt WR, Sussman KE. Peripheral arterial disease in the patient with diabetes mellitus. Can we make a difference? Diabetes Res Clin Pract. 1994 Jun; 24(2):65-7. PMID: 7956710.
      View in: PubMed
    244. Brass EP, Hoppel CL, Hiatt WR. Effect of intravenous L-carnitine on carnitine homeostasis and fuel metabolism during exercise in humans. Clin Pharmacol Ther. 1994 Jun; 55(6):681-92. PMID: 8004884.
      View in: PubMed
    245. Brass EP, Hiatt WR. Carnitine metabolism during exercise. Life Sci. 1994; 54(19):1383-93. PMID: 8190012.
      View in: PubMed
    246. Hiatt WR, Regensteiner JG, Wolfel EE. Special populations in cardiovascular rehabilitation. Peripheral arterial disease, non-insulin-dependent diabetes mellitus, and heart failure. Cardiol Clin. 1993 May; 11(2):309-21. PMID: 8508456.
      View in: PubMed
    247. Hiatt WR, Regensteiner JG. Nonsurgical management of peripheral arterial disease. Hosp Pract (Off Ed). 1993 Feb 15; 28(2):59-63, 67-70, 76-7 passim. PMID: 8432755.
      View in: PubMed
    248. Regensteiner JG, Wolfel EE, Brass EP, Carry MR, Ringel SP, Hargarten ME, Stamm ER, Hiatt WR. Chronic changes in skeletal muscle histology and function in peripheral arterial disease. Circulation. 1993 Feb; 87(2):413-21. PMID: 8425290.
      View in: PubMed
    249. Regensteiner JG, Hargarten ME, Rutherford RB, Hiatt WR. Functional benefits of peripheral vascular bypass surgery for patients with intermittent claudication. Angiology. 1993 Jan; 44(1):1-10. PMID: 8424578.
      View in: PubMed
    250. Hiatt WR, Jones DN. The role of hemodynamics and duplex ultrasound in the diagnosis of peripheral arterial disease. Curr Opin Cardiol. 1992 Oct; 7(5):805-10. PMID: 10147728.
      View in: PubMed
    251. Hiatt WR. Contemporary treatment of venous lower limb ulcers. Angiology. 1992 Oct; 43(10):852-5. PMID: 1476273.
      View in: PubMed
    252. Hiatt WR, Wolfel EE, Regensteiner JG, Brass EP. Skeletal muscle carnitine metabolism in patients with unilateral peripheral arterial disease. J Appl Physiol (1985). 1992 Jul; 73(1):346-53. PMID: 1506390.
      View in: PubMed
    253. Hiatt WR, Koziol BJ, Shapiro JI, Brass EP. Carnitine metabolism during exercise in patients on chronic hemodialysis. Kidney Int. 1992 Jun; 41(6):1613-9. PMID: 1501417.
      View in: PubMed
    254. England JD, Regensteiner JG, Ringel SP, Carry MR, Hiatt WR. Muscle denervation in peripheral arterial disease. Neurology. 1992 May; 42(5):994-9. PMID: 1579257.
      View in: PubMed
    255. Hiatt WR. Exercise physiology in cardiovascular diseases. Curr Opin Cardiol. 1991 Oct; 6(5):745-9. PMID: 10149590.
      View in: PubMed
    256. Faerber TH, Hiatt WR. Hemangioma of the frontal bone: review of the literature and report of a case. J Oral Maxillofac Surg. 1991 Sep; 49(9):1018-22. PMID: 1886013.
      View in: PubMed
    257. Regensteiner JG, Hiatt WR, Byyny RL, Pickett CK, Woodard WD, Moore LG. Short-term effects of estrogen and progestin on blood pressure of normotensive postmenopausal women. J Clin Pharmacol. 1991 Jun; 31(6):543-8. PMID: 1652597.
      View in: PubMed
    258. Hiatt WR, Regensteiner JG, Hargarten ME, Wolfel EE, Brass EP. Benefit of exercise conditioning for patients with peripheral arterial disease. Circulation. 1990 Feb; 81(2):602-9. PMID: 2404633.
      View in: PubMed
    259. Wolfel EE, Hiatt WR, Brammell HL, Travis V, Horwitz LD. Plasma catecholamine responses to exercise after training with beta-adrenergic blockade. J Appl Physiol (1985). 1990 Feb; 68(2):586-93. PMID: 1969402.
      View in: PubMed
    260. Hiatt WR, Marshall JA, Baxter J, Sandoval R, Hildebrandt W, Kahn LR, Hamman RF. Diagnostic methods for peripheral arterial disease in the San Luis Valley Diabetes Study. J Clin Epidemiol. 1990; 43(6):597-606. PMID: 2189949.
      View in: PubMed
    261. Hiatt WR, Regensteiner JG, Wolfel EE, Ruff L, Brass EP. Carnitine and acylcarnitine metabolism during exercise in humans. Dependence on skeletal muscle metabolic state. J Clin Invest. 1989 Oct; 84(4):1167-73. PMID: 2794054; PMCID: PMC329774.
    262. Hiatt WR, Huang SY, Regensteiner JG, Micco AJ, Ishimoto G, Manco-Johnson M, Drose J, Reeves JT. Venous occlusion plethysmography reduces arterial diameter and flow velocity. J Appl Physiol (1985). 1989 May; 66(5):2239-44. PMID: 2745287.
      View in: PubMed
    263. Ades PA, Wolfel EE, Hiatt WR, Fee C, Rolfs R, Brammell HL, Horwitz LD. Exercise haemodynamic effects of beta-blockade and intrinsic sympathomimetic activity. Eur J Clin Pharmacol. 1989; 36(1):5-10. PMID: 2917588.
      View in: PubMed
    264. Klein C, Hiatt WR, Gerber JG, Nies AS. Age does not alter human vascular and nonvascular beta 2-adrenergic responses to isoproterenol. Clin Pharmacol Ther. 1988 Nov; 44(5):573-8. PMID: 2846225.
      View in: PubMed
    265. Klein C, Hiatt WR, Gerber JG, Nies AS. The balance between vascular alpha- and beta-adrenoceptors is not changed in the elderly. Clin Pharmacol Ther. 1987 Sep; 42(3):260-4. PMID: 3040315.
      View in: PubMed
    266. Hiatt WR, Nawaz D, Brass EP. Carnitine metabolism during exercise in patients with peripheral vascular disease. J Appl Physiol (1985). 1987 Jun; 62(6):2383-7. PMID: 3610932.
      View in: PubMed
    267. Wolfel EE, Hiatt WR, Brammell HL, Carry MR, Ringel SP, Travis V, Horwitz LD. Effects of selective and nonselective beta-adrenergic blockade on mechanisms of exercise conditioning. Circulation. 1986 Oct; 74(4):664-74. PMID: 2875812.
      View in: PubMed
    268. Hiatt WR, Stoll S, Nies AS. Effect of beta-adrenergic blockers on the peripheral circulation in patients with peripheral vascular disease. Circulation. 1985 Dec; 72(6):1226-31. PMID: 2866047.
      View in: PubMed
    269. Hiatt WR, Travis VL, Horwitz KB, Horwitz LD. The effect of platelet protein and DNA on the measurement of human lymphocyte beta adrenergic receptor number. J Recept Res. 1985; 5(5-6):419-29. PMID: 3003354.
      View in: PubMed
    270. Hiatt WR, Wolfel EE, Stoll S, Nies AS, Zerbe GO, Brammell HL, Horwitz LD. beta-2 Adrenergic blockade evaluated with epinephrine after placebo, atenolol, and nadolol. Clin Pharmacol Ther. 1985 Jan; 37(1):2-6. PMID: 2856902.
      View in: PubMed
    271. Hiatt WR, Marsh RC, Brammell HL, Fee C, Horwitz LD. Effect of aerobic conditioning on the peripheral circulation during chronic beta-adrenergic blockade. J Am Coll Cardiol. 1984 Nov; 4(5):958-63. PMID: 6491088.
      View in: PubMed
    272. Hiatt WR, Fradl DC, Zerbe GO, Byyny RL, Nies AS. Selective and nonselective beta-blockade of the peripheral circulation. Clin Pharmacol Ther. 1984 Jan; 35(1):12-8. PMID: 6690167.
      View in: PubMed
    273. Johnston GD, Hiatt WR, Nies AS, Payne NA, Murphy RC, Gerber JG. Factors modifying the early nondiuretic vascular effects of furosemide in man. The possible role of renal prostaglandins. Circ Res. 1983 Nov; 53(5):630-5. PMID: 6414733.
      View in: PubMed
    274. Marsh RC, Hiatt WR, Brammell HL, Horwitz LD. Attenuation of exercise conditioning by low dose beta-adrenergic receptor blockade. J Am Coll Cardiol. 1983 Sep; 2(3):551-6. PMID: 6135725.
      View in: PubMed
    275. Rutherford RB, Hiatt WR, Kreutzer EW. The use of velocity wave form analysis in the diagnosis of carotid artery occlusive disease. Surgery. 1977 Nov; 82(5):695-702. PMID: 918858.
      View in: PubMed
    276. Hong SK, Moore TO, Seto G, Park HK, Hiatt WR, Bernauer EM. Lung volumes and apneic bradycardia in divers. J Appl Physiol. 1970 Aug; 29(2):172-6. PMID: 5428891.
      View in: PubMed
    Hiatt's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _

    Copyright © 2017 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.10.0)